Clinical trial

Early Intermittent Intensive Insulin Therapy as an Effective Treatment of Type 2 Diabetes (RESET-IT Pilot Study)

NCT01755468

Study summary

ClinicalTrials.gov

Early Intermittent Intensive Insulin Therapy as an Effective Treatment of Type 2 Diabetes (RESET-IT Pilot Study)

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE3

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Unmapped registry intervention Intermittent insulin therapy Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Continuous metformin Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2013-04-01

PhasePHASE3

Conditions

Type 2 Diabetesverified · MONDO: type 2 diabetes mellitus

Interventions

Intermittent insulin therapyDRUG

Continuous metforminDRUG

Sponsors & collaborators

Mount Sinai Hospital, Canadalead sponsor

Canadian Institutes of Health Research (CIHR)collaborator

Mapped research locations

TorontoOntario, Canada1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01755468 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.